Robbert Boudewijns

7PUBLICATIONS
98CO-AUTHORS
Genetically modified animalsInnate immunityAnimal cell and molecular biologyMajor global burdens of diseaseAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 18, 2021
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.

Ji Ma, Robbert Boudewijns, Lorena Sanchez-Felipe

|Oct 05, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

Bert Schepens, Loes van Schie, Wim Nerinckx

|Nov 18, 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J F Kaptein

|Oct 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.

Suzanne J F Kaptein, Sofie Jacobs, Lana Langendries

|Apr 09, 2020
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.

Niraj Mishra, Robbert Boudewijns, Michael Alexander Schmid

|Mar 03, 2020
A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.

Dieudonné Buh Kum, Robbert Boudewijns, Ji Ma

Pageof 2

Frequent Collaborators

7 joint publications

Johan Neyts

6 joint publications

Kai Dallmeier

4 joint publications

Hendrik Jan Thibaut

3 joint publications

Niraj Mishra